Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Shrikster
AddedMar 31, 2024
UpdatedJul 2, 2026
Shrikster

Shrikster

Board Member, Tactile Systems Technology

Shrikster's Career

Tactile Systems Technology
Tactile Systems Technology

Minneapolis, MN, US

Board Member· Board
Sommetrics
Sommetrics

San Diego, CA, US

Board Member· Board
Wellfount
Wellfount

Indianapolis, IN, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Shrikster's Career

Tactile Systems Technology
Tactile Systems Technology
Public9822006Minneapolis, MN, US
Board Member· Board

Leadership at Tactile Systems Technology

Bill BurkeBill BurkeBoard Member
Irene WaldridgeIrene WaldridgeBoard Member
Antonios P GasparisAntonios P GasparisBoard Member
Dan ReuversDan ReuversBoard Member
Sommetrics
Sommetrics
Series C$28.5M152007San Diego, CA, US
Board Member· Board

Leadership at Sommetrics

Jerry AarestadJerry AarestadCo-Founder
Richard RoseRichard RoseBoard Member
Wally McCloskeyWally McCloskeyBoard Member

Similar to Sommetrics

SomneraSomneraSan Clemente, CA, USMedical Devicesest. 2011SomneraSan Clemente, CA, US · est. 2011

Somnera, a medical device company, enhances lives by tackling Obstructive Sleep Apnea.

Series C · $7.5M30
Somnea HealthSomnea HealthChicago, IL, USMedical Devicesest. 2022Somnea HealthChicago, IL, US · est. 2022

Somnea: Pioneering sleep apnea solutions through innovative wearable technology.

Pre-Seed · $120k9
WhisperSomWhisperSomAnnapolis, MD, USMedical Devicesest. 2014WhisperSomAnnapolis, MD, US · est. 2014

WhisperSom: Personalized neurostimulation devices for diagnosing and treating sleep apnea.

Seed · $4.8M8
NovaSomNovaSomGlen Burnie, MD, USMedical Devicesest. 1992NovaSomGlen Burnie, MD, US · est. 1992

NovaSom, Inc.: A leading U.S. provider of home diagnostic products for sleep disorders.

Series B · $114.6M125
Wellfount
Wellfount
$47.1M2002011Indianapolis, IN, US
Board Member· Board

Leadership at Wellfount

Paul McCreadiePaul McCreadieBoard Member

Similar to Wellfount

Partners PharmacyPartners PharmacyCranford, NJ, USPharmacy Servicesest. 1998Partners PharmacyCranford, NJ, US · est. 1998

Partners Pharmacy Inc: A US-based long-term care pharmacy, serving medication needs of care facilities.

Series D · $60M508
AlixaRxAlixaRxPlano, TX, USClinical Services, Pharmacyest. 2011AlixaRxPlano, TX, US · est. 2011

Innovative pharmacy and clinical services provider for long-term care and skilled nursing.

Private Equity · $100M750
Remedi SeniorCareRemedi SeniorCareBaltimore, MD, USHealthcare, Pharmacyest. 2017Remedi SeniorCareBaltimore, MD, US · est. 2017

Remedi SeniorCare: Comprehensive pharmacy services and healthcare solutions provider across the US.

Private Equity · $301M7.5k

People Similar to Shrikster

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · KakaoAndrew FlettAndrew FlettBoard Member · AmpathyShirish SathayeShirish SathayeBoard Member · Flex Logix TechnologiesGerald J. BurnettGerald J. BurnettBoard Member · Avistar CommunicationsJill SchiaparelliJill SchiaparelliBoard Member · Avation MedicalRaymond HuggenbergerRaymond HuggenbergerBoard Member · InogenGreg GoffGreg GoffBoard Member · X-energy